Login
MANGOCEUTICALS, INC. logo

MANGOCEUTICALS, INC.

mangorx.com

What Do They Do?

Connects consumers with licensed healthcare professionals through telehealth and sells men’s wellness products, including treatments for erectile dysfunction, hair loss and weight management, to patients.

How Do They Make Money?

Consumers buy products and services directly through the company’s website. Product sales are counted when products are delivered to a carrier; consultation services are counted over the few days the consultation takes place.

FY2025 revenue

Who Are Their Customers?

Individual consumers use the company’s website to buy products and services, with prescriptions reviewed by licensed medical providers and orders fulfilled through a partner compounding pharmacy.

Do Revenues Turn Into Profits?

No. It lost $20.6M in FY2025.

Operating income, FY2025
−3954% of revenue
▼ −126% (Loss) vs FY2024 (−$8M, −1294%)
Net income, FY2025
−4527% of revenue
▼ −137% (Loss) vs FY2024 (−$8.7M, −1414%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▼ −17%
vs $84.2K in Q3 FY2025
Net income
▲ +53% (Loss)
vs −$7.6M in Q3 FY2025
  • Sep 30, 2026 Investors bought a 25% stake in MangoRx IP for $2.5 million The company reported receiving $1.75 million of the investment, with the remaining $750,000 due by November 28, 2026.
  • Aug 19, 2026 Mangoceuticals and Nuclea ended their planned business combination The parties terminated the agreement after they could not raise the required financing by the deadline.
  • Jul 28, 2026 Mangoceuticals agreed to combine with Nuclea Energy The agreement contemplated Nuclea shareholders holding approximately 96% of the combined company before the planned financing.

Who Do They Compete With?

Competes with Hims & Hers Health, Roman, Pfizer, Lilly ICOS, Merck &, and Johnson & Johnson

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support